{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T22:30:55Z","timestamp":1773527455902,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Taiwan Motor Neuron Disease Association","award":["TMND"],"award-info":[{"award-number":["TMND"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00415-019-09405-x","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T16:02:20Z","timestamp":1559318540000},"page":"2233-2243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"266","author":[{"given":"Ching-Piao","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny Kuang-Wu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5958-3680","authenticated-orcid":false,"given":"Charles Tzu-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"issue":"7","key":"9405_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jfma.2013.01.008","volume":"114","author":"CP Tsai","year":"2015","unstructured":"Tsai CP, Wang KC, Hwang CS, Lee IT, Lee CT (2015) Incidence, prevalence, and medical expenditures of classical amyotrophic lateral sclerosis in Taiwan, 1999\u20132008. J Formos Med Assoc 114(7):612\u2013619. \n                    https:\/\/doi.org\/10.1016\/j.jfma.2013.01.008","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"9405_CR2","first-page":"528","volume":"38","author":"V Holecek","year":"2018","unstructured":"Holecek V, Rokyta R (2018) Possible etiology and treatment of amyotrophic lateral sclerosis. Neuro Endocrinol Lett 38(8):528\u2013531","journal-title":"Neuro Endocrinol Lett"},{"key":"9405_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2016.00047","volume":"7","author":"SK Hollinger","year":"2016","unstructured":"Hollinger SK, Okosun IS, Mitchell CS (2016) Antecedent disease and amyotrophic lateral sclerosis: what is protecting whom? Front Neurol 7:47. \n                    https:\/\/doi.org\/10.3389\/fneur.2016.00047","journal-title":"Front Neurol"},{"issue":"4","key":"9405_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 258(4):613\u2013617. \n                    https:\/\/doi.org\/10.1007\/s00415-010-5805-z","journal-title":"J Neurol"},{"issue":"5","key":"9405_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1468-1331.2009.02923.x","volume":"17","author":"A Jawaid","year":"2010","unstructured":"Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE (2010) ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol 17(5):733\u2013739. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02923.x","journal-title":"Eur J Neurol"},{"issue":"9","key":"9405_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","volume":"80","author":"V Gallo","year":"2013","unstructured":"Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, Andersen PM, Hallmans G, Kyrozis A, Vanacore N, Vahdaninia M, Grote V, Kaaks R, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Travis RC, Petersson J, Hansson O, Arriola L, Jimenez-Martin JM, Tjonneland A, Halkjaer J, Agnoli C, Sacerdote C, Bonet C, Trichopoulou A, Gavrila D, Overvad K, Weiderpass E, Palli D, Quiros JR, Tumino R, Khaw KT, Wareham N, Barricante-Gurrea A, Fedirko V, Ferrari P, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Vigl M, Middleton L, Riboli E, Vineis P (2013) Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology 80(9):829\u2013838. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182840689","journal-title":"Neurology"},{"issue":"2","key":"9405_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ene.12667","volume":"23","author":"J Ji","year":"2016","unstructured":"Ji J, Sundquist J, Sundquist K (2016) Association of alcohol use disorders with amyotrophic lateral sclerosis: a Swedish National Cohort Study. Eur J Neurol 23(2):270\u2013275. \n                    https:\/\/doi.org\/10.1111\/ene.12667","journal-title":"Eur J Neurol"},{"issue":"1","key":"9405_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-018-0294-0","volume":"13","author":"A Jawaid","year":"2018","unstructured":"Jawaid A, Khan R, Polymenidou M, Schulz PE (2018) Disease-modifying effects of metabolic perturbations in ALS\/FTLD. Mol Neurodegener 13(1):63. \n                    https:\/\/doi.org\/10.1186\/s13024-018-0294-0","journal-title":"Mol Neurodegener"},{"issue":"1","key":"9405_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/ene.13465","volume":"25","author":"F D'Ovidio","year":"2018","unstructured":"D'Ovidio F, d'Errico A, Carna P, Calvo A, Costa G, Chio A (2018) The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis. Eur J Neurol 25(1):164\u2013170. \n                    https:\/\/doi.org\/10.1111\/ene.13465","journal-title":"Eur J Neurol"},{"issue":"8","key":"9405_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamaneurol.2015.0910","volume":"72","author":"MA Kioumourtzoglou","year":"2015","unstructured":"Kioumourtzoglou MA, Rotem RS, Seals RM, Gredal O, Hansen J, Weisskopf MG (2015) Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study. JAMA Neurol 72(8):905\u2013911. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2015.0910","journal-title":"JAMA Neurol"},{"issue":"11","key":"9405_CR11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/ene.12632","volume":"22","author":"D Mariosa","year":"2015","unstructured":"Mariosa D, Kamel F, Bellocco R, Ye W, Fang F (2015) Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol 22(11):1436\u20131442. \n                    https:\/\/doi.org\/10.1111\/ene.12632","journal-title":"Eur J Neurol"},{"issue":"6","key":"9405_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ana.24801","volume":"80","author":"MR Turner","year":"2016","unstructured":"Turner MR, Goldacre R, Talbot K, Goldacre MJ (2016) Psychiatric disorders prior to amyotrophic lateral sclerosis. Ann Neurol 80(6):935\u2013938. \n                    https:\/\/doi.org\/10.1002\/ana.24801","journal-title":"Ann Neurol"},{"issue":"6","key":"9405_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","volume":"82","author":"NA Sutedja","year":"2011","unstructured":"Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, Van den Berg LH (2011) Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82(6):638\u2013642. \n                    https:\/\/doi.org\/10.1136\/jnnp.2010.236752","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"9405_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/jnnp.2011.241539","volume":"82","author":"O Hardiman","year":"2011","unstructured":"Hardiman O (2011) Amyotrophic lateral sclerosis and vascular risk: a metabolic conundrum. J Neurol Neurosurg Psychiatry 82(6):591. \n                    https:\/\/doi.org\/10.1136\/jnnp.2011.241539","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"9405_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jnnp-2015-311157","volume":"87","author":"MR Turner","year":"2015","unstructured":"Turner MR, Goldacre R, Talbot K, Goldacre MJ (2015) Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 87(3):244\u2013246. \n                    https:\/\/doi.org\/10.1136\/jnnp-2015-311157","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"9405_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S1474-4422(14)70177-2","volume":"13","author":"G Logroscino","year":"2014","unstructured":"Logroscino G, Ludolph A (2014) Amyotrophic lateral sclerosis: new ideas from cancer. Lancet Neurol 13(11):1067\u20131068. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(14)70177-2","journal-title":"Lancet Neurol"},{"issue":"3","key":"9405_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.0000000000002757","volume":"87","author":"SB Gibson","year":"2016","unstructured":"Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2016) Population-based risks for cancer in patients with ALS. Neurology 87(3):289\u2013294. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002757","journal-title":"Neurology"},{"issue":"14","key":"9405_CR18","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1212\/WNL.0b013e3182a6cc13","volume":"81","author":"MR Turner","year":"2013","unstructured":"Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ (2013) Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81(14):1222\u20131225","journal-title":"Neurology"},{"issue":"3","key":"9405_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/mus.24688","volume":"52","author":"S Paganoni","year":"2015","unstructured":"Paganoni S, Hyman T, Shui A, Allred P, Harms M, Liu J, Maragakis N, Schoenfeld D, Yu H, Atassi N (2015) Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis. Muscle Nerve 52(3):339\u2013343","journal-title":"Muscle Nerve"},{"issue":"6","key":"9405_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2188\/jea.JE20140176","volume":"25","author":"Y Sun","year":"2015","unstructured":"Sun Y, Lu CJ, Chen RC, Hou WH, Li CY (2015) Risk of amyotrophic lateral sclerosis in patients with diabetes: a nationwide population-based cohort study. J Epidemiol 25(6):445\u2013451. \n                    https:\/\/doi.org\/10.2188\/jea.JE20140176","journal-title":"J Epidemiol"},{"issue":"7","key":"9405_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ijc.28795","volume":"135","author":"DM Freedman","year":"2014","unstructured":"Freedman DM, Wu J, Daugherty SE, Kuncl RW, Enewold LR, Pfeiffer RM (2014) The risk of amyotrophic lateral sclerosis after cancer in US elderly adults: a population-based prospective study. Int J Cancer 135(7):1745\u20131750. \n                    https:\/\/doi.org\/10.1002\/ijc.28795","journal-title":"Int J Cancer"},{"key":"9405_CR22","unstructured":"National Health Research Institute (1998) Introduction to the national health insurance research database (NHIRD). Taiwan. \n                    http:\/\/nhird.nhri.org.tw\/en\/\n                    \n                  . Retrieved May 2019"},{"issue":"3","key":"9405_CR23","first-page":"157","volume":"104","author":"CC Lin","year":"2005","unstructured":"Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY (2005) Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 104(3):157\u2013163","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"9405_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-018-1835-x","volume":"135","author":"T Vandoorne","year":"2018","unstructured":"Vandoorne T, De Bock K, Van Den Bosch L (2018) Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol 135(4):489\u2013509. \n                    https:\/\/doi.org\/10.1007\/s00401-018-1835-x","journal-title":"Acta Neuropathol"},{"issue":"1","key":"9405_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis L, Pradat PF, Ludolph AC, Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10(1):75\u201382. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(10)70224-6","journal-title":"Lancet Neurol"},{"issue":"2","key":"9405_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000369812","volume":"15","author":"CS Mitchell","year":"2015","unstructured":"Mitchell CS, Hollinger SK, Goswami SD, Polak MA, Lee RH, Glass JD (2015) Antecedent disease is less prevalent in amyotrophic lateral sclerosis. Neurodegener Dis 15(2):109\u2013113. \n                    https:\/\/doi.org\/10.1159\/000369812","journal-title":"Neurodegener Dis"},{"issue":"4","key":"9405_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/cn500363g","volume":"6","author":"P Kaur","year":"2015","unstructured":"Kaur P, Muthuraman A, Kaur M (2015) The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci 6(4):508\u2013521. \n                    https:\/\/doi.org\/10.1021\/cn500363g","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"9405_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/jamaneurol.2014.3367","volume":"72","author":"FC Lin","year":"2015","unstructured":"Lin FC, Tsai CP, Kuang-Wu Lee J, Wu MT, Tzu-Chi Lee C (2015) Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study. JAMA Neurol 72(1):40\u201348. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2014.3367","journal-title":"JAMA Neurol"},{"issue":"5","key":"9405_CR29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa D, Hammar N, Malmstrom H, Ingre C, Jungner I, Ye W, Fang F, Walldius G (2017) Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol 81(5):718\u2013728. \n                    https:\/\/doi.org\/10.1002\/ana.24936","journal-title":"Ann Neurol"},{"issue":"2","key":"9405_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3906\/sag-1410-40","volume":"46","author":"E Taylan","year":"2016","unstructured":"Taylan E, Tuncel EP (2016) Distribution of LDL subgroups in patients with hyperlipidemia. Turk J Med Sci 46(2):374\u2013380. \n                    https:\/\/doi.org\/10.3906\/sag-1410-40","journal-title":"Turk J Med Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09405-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09405-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T23:27:50Z","timestamp":1590794870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09405-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["9405"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09405-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"17 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}